Afanat30mg

About Afanat30mg

Afanat 30 mg tablet is used for non-small cell lung cancer treatment in adults with certain mutations of epidermal growth factor receptor (EGFR). It contains Afatinib as an active FDA approved ingredient. Afanat 30 mg tablet is a tyrosine kinase inhibitors (TKIs) prescribed for metastatic & squamous non-small cell lung cancer. It works by targeting specific proteins involved in cancer cell growth & does not affect normal cells of the body.